local_hospital

Staedtisches Klinikum Braunschweig gGmbH

Address
Salzdahlumer Str. 90, 38126 Braunschweig, Germany

Staedtisches Klinikum Braunschweig gGmbH - Pediatric Oncology Center

Staedtisches Klinikum Braunschweig gGmbH is a distinguished clinical research institution with specialized expertise in pediatric hematology and oncology. The center demonstrates a strong commitment to advancing treatment options for children with complex hematologic malignancies, particularly focusing on rare and challenging patient populations.

  • Myeloid leukemia research in children with Down syndrome
  • Phase III clinical trials for novel chemotherapy combinations
  • Pediatric oncology and specialized leukemia treatments

The center is actively engaged in innovative therapeutic approaches, including the investigation of CPX-351 for myeloid leukemia in children with Down syndrome. This research aims to achieve non-inferior event-free survival outcomes compared to established treatment protocols, demonstrating the institution's dedication to improving long-term survival rates and quality of life for pediatric patients with rare hematologic conditions.

Site Overview

assignment
3
connected trials
corporate_fare
2
sponsors
science
8
IMPs

Activity Indicator

Last 6 months

0
Trials started
0
Trials started 6–12 months ago
3
Total trials linked
Moderately Active
trending_flatStable0%
Mar
Apr
May
Jun
Jul
Aug

Trial Flow

How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.

Therapeutic areaarrow_forwardIMParrow_forwardLifecycle status
lock Available on a paid plan

Compounds & Molecules Timeline

The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.

Trial span Ongoing Showing last 8 years
lock Available on a paid plan

Sponsor & Partnership

Top sponsors by active trials, and the ones that have come back for more than one study.

Active trials
3
Sponsors (total)
2
Active sponsors
2

Sponsor Network

Top 2 by active trials.

lock +1 more on a paid plan

Partnership History

Sponsors with repeated collaboration (≥ 2 trials).

Sponsor Network Graph

How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.

Country Benchmark

Compared to 2 161 other sites in Germany

description
Trial volume
3
Outperforms 61% of sites
public
Therapeutic diversity
4areas
Outperforms 86% of sites
groups
Sponsor diversity
2sponsors
Outperforms 51% of sites

Therapeutic Area Benchmark — Germany

Select a therapeutic area to compare against other sites in Germany.

Competitor Comparison

Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.

Country: Germany

Market Share

Country: Germany

Therapeutic Area Market Share

Select a therapeutic area to view its disease coverage breakdown.

Heat Maps & Advanced Analytics

How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.

Other Trials in Staedtisches Klinikum Braunschweig gGmbH

lock Showing 1 of 3 trials — the rest is available on a paid plan.

Trial Sponsor Phase Status Start Date End Date
Evaluation of Transdermal Nicotine on Delayed Gastric Emptying Post-Pancreatoduodenectomy: A Randomized, Double-Blind, Placebo-Controlled Multicenter TrialRheinische Friedrich-Wilhelms-Universitaet BonnPhase IIRecruitingOct 2023

IMP list

lock Showing 1 of 8 compounds — the rest is available on a paid plan.

IMP Trials Status First start Last start
Carboplatin1Unknown2019-12-052019-12-05

Request feasibility information

Ask this centre about capacity, equipment and patient population.

Upgrade this site to Business Plan

Own the profile, publish your feasibility data and reach sponsors directly.

Is something out of date?

Tell us what needs correcting and we'll update this profile.

lock Available to Business plan sites only.